203 related articles for article (PubMed ID: 22901430)
1. Activation of the canonical Wnt/β-catenin signalling pathway is rare in canine malignant melanoma tissue and cell lines.
Chon E; Thompson V; Schmid S; Stein TJ
J Comp Pathol; 2013 Feb; 148(2-3):178-87. PubMed ID: 22901430
[TBL] [Abstract][Full Text] [Related]
2. [Nuclear beta-catenin localization is not sufficient for canonical Wnt signaling activation in human meianoma cell lines].
Kulikova KV; Posviatenko AV; Gnuchev NV; Georgiev GP; Kibardin AV; Larin SS
Mol Biol (Mosk); 2011; 45(5):884-91. PubMed ID: 22393786
[TBL] [Abstract][Full Text] [Related]
3. Canine cutaneous melanocytic tumours: significance of β-catenin and survivin immunohistochemical expression.
Bongiovanni L; D'Andrea A; Porcellato I; Ciccarelli A; Malatesta D; Romanucci M; Della Salda L; Mechelli L; Brachelente C
Vet Dermatol; 2015 Aug; 26(4):270-e59. PubMed ID: 25962968
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of the Wnt/beta-catenin signaling pathway in canine cutaneous melanotic tumor.
Han JI; Kim DY; Na KJ
Vet Pathol; 2010 Mar; 47(2):285-91. PubMed ID: 20139375
[TBL] [Abstract][Full Text] [Related]
5. Alteration in E-cadherin/β-catenin expression in canine melanotic tumors.
Han JI; Kim Y; Kim DY; Na KJ
Vet Pathol; 2013 Mar; 50(2):274-80. PubMed ID: 22895538
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Wnt/β-catenin and Notch signalling in the activated canine hepatic progenitor cell niche.
Schotanus BA; Kruitwagen HS; van den Ingh TS; van Wolferen ME; Rothuizen J; Penning LC; Spee B
BMC Vet Res; 2014 Dec; 10():309. PubMed ID: 25551829
[TBL] [Abstract][Full Text] [Related]
7. The role of Wnt/β-catenin signaling pathway in melanoma epithelial-to-mesenchymal-like switching: evidences from patients-derived cell lines.
Kovacs D; Migliano E; Muscardin L; Silipo V; Catricalà C; Picardo M; Bellei B
Oncotarget; 2016 Jul; 7(28):43295-43314. PubMed ID: 27175588
[TBL] [Abstract][Full Text] [Related]
8. Cell proliferation and expression of connexins differ in melanotic and amelanotic canine oral melanomas.
Teixeira TF; Gentile LB; da Silva TC; Mennecier G; Chaible LM; Cogliati B; Roman MA; Gioso MA; Dagli ML
Vet Res Commun; 2014 Mar; 38(1):29-38. PubMed ID: 24126842
[TBL] [Abstract][Full Text] [Related]
9. β-Catenin transcriptional activity is minimal in canine osteosarcoma and its targeted inhibition results in minimal changes to cell line behaviour.
Piskun CM; Stein TJ
Vet Comp Oncol; 2016 Jun; 14(2):e4-e16. PubMed ID: 24256430
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of MAPK and PI3K/AKT pathway activation and inhibition in human and canine melanoma.
Fowles JS; Denton CL; Gustafson DL
Vet Comp Oncol; 2015 Sep; 13(3):288-304. PubMed ID: 23745794
[TBL] [Abstract][Full Text] [Related]
11. Change in β-catenin localization suggests involvement of the canonical Wnt pathway in Boxer dogs with arrhythmogenic right ventricular cardiomyopathy.
Oxford EM; Danko CG; Fox PR; Kornreich BG; Moïse NS
J Vet Intern Med; 2014; 28(1):92-101. PubMed ID: 24428316
[TBL] [Abstract][Full Text] [Related]
12. 6-Bromoindirubin-3'oxime (BIO) decreases proliferation and migration of canine melanoma cell lines.
Chon E; Flanagan B; de Sá Rodrigues LC; Piskun C; Stein TJ
Vet J; 2015 Aug; 205(2):305-12. PubMed ID: 25130776
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of expression of the Wnt signaling components in canine mammary tumors via RT
Yu F; Rasotto R; Zhang H; Pei S; Zhou B; Yang X; Jin Y; Zhang D; Lin D
J Vet Sci; 2017 Sep; 18(3):359-367. PubMed ID: 27586466
[TBL] [Abstract][Full Text] [Related]
14. Characterization of β-catenin expression in canine osteosarcoma.
Stein TJ; Holmes KE; Muthuswamy A; Thompson V; Huelsmeyer MK
Vet Comp Oncol; 2011 Mar; 9(1):65-73. PubMed ID: 21303455
[TBL] [Abstract][Full Text] [Related]
15. Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma.
Simpson RM; Bastian BC; Michael HT; Webster JD; Prasad ML; Conway CM; Prieto VM; Gary JM; Goldschmidt MH; Esplin DG; Smedley RC; Piris A; Meuten DJ; Kiupel M; Lee CC; Ward JM; Dwyer JE; Davis BJ; Anver MR; Molinolo AA; Hoover SB; Rodriguez-Canales J; Hewitt SM
Pigment Cell Melanoma Res; 2014 Jan; 27(1):37-47. PubMed ID: 24128326
[TBL] [Abstract][Full Text] [Related]
16. 6-Bromoindirubin-3'-oxime promotes osteogenic differentiation of canine BMSCs through inhibition of GSK3β activity and activation of the Wnt/β-catenin signaling pathway.
Zhao XE; Yang Z; Gao Z; Ge J; Wei Q; Ma B
An Acad Bras Cienc; 2019 Mar; 91(1):e20180459. PubMed ID: 30916158
[TBL] [Abstract][Full Text] [Related]
17. Activation of the canonical WNT signaling pathway promotes ovarian surface epithelial proliferation without inducing β-catenin/Tcf-mediated reporter expression.
Usongo M; Li X; Farookhi R
Dev Dyn; 2013 Mar; 242(3):291-300. PubMed ID: 23239518
[TBL] [Abstract][Full Text] [Related]
18. Ligand-independent canonical Wnt activity in canine mammary tumor cell lines associated with aberrant LEF1 expression.
Gracanin A; Timmermans-Sprang EP; van Wolferen ME; Rao NA; Grizelj J; Vince S; Hellmen E; Mol JA
PLoS One; 2014; 9(6):e98698. PubMed ID: 24887235
[TBL] [Abstract][Full Text] [Related]
19. Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype.
Sinnberg T; Levesque MP; Krochmann J; Cheng PF; Ikenberg K; Meraz-Torres F; Niessner H; Garbe C; Busch C
Mol Cancer; 2018 Feb; 17(1):59. PubMed ID: 29454361
[TBL] [Abstract][Full Text] [Related]
20. Chondroitin sulfate proteoglycan-4: a biomarker and a potential immunotherapeutic target for canine malignant melanoma.
Mayayo SL; Prestigio S; Maniscalco L; Rosa G; Aricò A; Maria R; Cavallo F; Ferrone S; Buracco P; Iussich S
Vet J; 2011 Nov; 190(2):e26-e30. PubMed ID: 21482159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
